Cutaneous Lymphocytic Vasculitis After Administration of the Second Dose of AZD1222 (Oxford–AstraZeneca) Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination: Casuality or Causality?
No abstract available
Source: The American Journal of Dermatopathology - Category: Pathology Tags: Letters to the Editor Source Type: research
More News: AstraZeneca | Coronavirus | COVID-19 | Dermatology | Pathology | Respiratory Medicine | SARS | Vaccines | Vasculitis